The legal imperative for treating rare disorders

BACKGROUND: Life-saving orphan drugs are some of the most expensive medicines. European Union governments aim to accommodate their provision within stretched healthcare budgets but face pressure to reduce funding of such treatments. Patients struggle to retain or gain access to them as their special...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyry, Hanna I, Roos, Jonathan CP, Manuel, Jeremy, Cox, Timothy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016581/
https://www.ncbi.nlm.nih.gov/pubmed/24010951
http://dx.doi.org/10.1186/1750-1172-8-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016581/
https://www.ncbi.nlm.nih.gov/pubmed/24010951
http://dx.doi.org/10.1186/1750-1172-8-135

Ejemplares similares